Results 11 to 20 of about 1,157 (167)

Rhesus-D zygosity and hemolytic disease of fetus and newborn

open access: yesAsian Journal of Transfusion Science, 2013
Alloimmunization against the Rhesus-D (RhD) antigen still remains as a major cause of hemolytic disease of fetus and newborn (HDFN). Determination of paternal RhDzygosity is performed by molecular testing and is valuable for the management of ...
Mostafa Moghaddam   +3 more
doaj   +2 more sources

Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2022
Objective: Hemolytic disease of the fetus and newborn (HDFN) caused by irregular antibodies is a rare, but possibly life-threatening condition. We report a case of severe intrauterine hemolysis caused by anti-E alloimmunization, and review 16 cases in ...
Ming-Ta Chuang, Chiung-Hsin Chang
doaj   +2 more sources

Hemolytic disease of newborn following anti-C and anti-S alloimmunization: A case report with review of literature

open access: yesIndian Pediatrics Case Reports, 2023
Background: Non-Rhesus D antigen non-ABO, minor blood group alloimmunization in pregnant women is being increasingly recognized as a significant contributor to the development of the hemolytic disease of the fetus and newborn (HDFN).
Shrutiprajna Kar   +3 more
doaj   +2 more sources

Hemolytic disease of fetus and newborn due to maternal AlloAnti-S antibody

open access: yesAsian Journal of Transfusion Science
Hemolytic disease of foetus and newborn (HDFN) is a disease characterized by the destruction of fetal red cells by the maternal antibodies which occurs due to allo immunization in the mother by feto-maternal blood group incompatibility.The antibodies ...
Suresh Kumar Iyyapan   +3 more
doaj   +2 more sources

HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) – CASE REPORT [PDF]

open access: yesZdravniški Vestnik, 2003
Background. Hemolytic disease of the fetus and newborn (HDFN) develops because of the passage of maternal erythrocyte alloantibodies through the placenta. These antibodies cause a reduction of the erythrocyte life span in the fetus and newborn.
Irena Bricl   +2 more
doaj   +1 more source

Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of RHD, KEL, and RHCE from Cell-Free Fetal DNA of Maternal Plasma

open access: yesDiagnostics, 2021
The molecular pathology of hemolytic disease of the fetus and newborn (HDFN) is determined by different RHD, RHCE, and KEL genotypes and by blood group incompatibility between the mother and fetus that is caused by erythrocyte antigen presence/absence on
Radek Vodicka   +5 more
doaj   +2 more sources

Approach to Pregnancy Affected by Kell Alloimmunization

open access: yesCase Reports in Hematology
Hemolytic disease of the fetus and newborn (HDFN) is the development of anemia, hyperbilirubinemia, and finally hydrops fetalis in the fetus when antibodies to antigens on the surface of erythrocytes are transferred from the placenta to the fetus.
Serdar Aykut   +7 more
doaj   +2 more sources

Kell alloimmunization in pregnancy: Lessons to be learnt

open access: yesGlobal Journal of Transfusion Medicine, 2017
With the introduction of anti-D prophylaxis, the incidence of RhD alloimmunization in pregnancy has been significantly reduced. RhD remains the most common cause of hemolytic disease of fetus and newborn (HDFN).
Rajeswari Subramaniyan
doaj   +2 more sources

Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population

open access: yesAsian Journal of Transfusion Science, 2014
Background: Maternal red blood cell (RBC) alloimmunization may lead to production of harmful antibodies that result in hemolytic disease of fetus and newborn (HDFN).
Mohd Nazri Hassan   +5 more
doaj   +2 more sources

Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion

open access: yesAsian Journal of Transfusion Science, 2018
ABO incompatibility and other alloantibodies have emerged as a significant cause of hemolytic disease of fetus and newborn (HDFN), leading to neonatal morbidity and mortality.
Ashish Jain   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy